Free Trial

Verona Pharma PLC American Depositary Share (VRNA) Stock Price, News & Analysis

Verona Pharma PLC American Depositary Share logo
$105.40 +0.01 (+0.01%)
Closing price 08/7/2025 04:00 PM Eastern
Extended Trading
$104.90 -0.50 (-0.47%)
As of 08/7/2025 07:54 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Verona Pharma PLC American Depositary Share Stock (NASDAQ:VRNA)

Key Stats

Today's Range
$105.19
$105.40
50-Day Range
$80.83
$105.47
52-Week Range
$19.75
$105.50
Volume
1.86 million shs
Average Volume
5.00 million shs
Market Capitalization
$8.97 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$109.00
Consensus Rating
Hold

Company Overview

Verona Pharma PLC American Depositary Share Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
38th Percentile Overall Score

VRNA MarketRank™: 

Verona Pharma PLC American Depositary Share scored higher than 38% of companies evaluated by MarketBeat, and ranked 745th out of 921 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Verona Pharma PLC American Depositary Share has received a consensus rating of Hold. The company's average rating score is 2.15, and is based on 2 buy ratings, 11 hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    Verona Pharma PLC American Depositary Share has been the subject of 12 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

  • Read more about Verona Pharma PLC American Depositary Share's stock forecast and price target.
  • Earnings Growth

    Earnings for Verona Pharma PLC American Depositary Share are expected to grow in the coming year, from ($1.95) to $0.03 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Verona Pharma PLC American Depositary Share is -106.46, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Verona Pharma PLC American Depositary Share is -106.46, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    Verona Pharma PLC American Depositary Share has a P/B Ratio of 41.17. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Read more about Verona Pharma PLC American Depositary Share's valuation and earnings.
  • Percentage of Shares Shorted

    4.77% of the outstanding shares of Verona Pharma PLC American Depositary Share have been sold short.
  • Short Interest Ratio / Days to Cover

    Verona Pharma PLC American Depositary Share has a short interest ratio ("days to cover") of 1.2, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Verona Pharma PLC American Depositary Share has recently increased by 6,533.99%, indicating that investor sentiment is decreasing significantly.
  • Dividend Yield

    Verona Pharma PLC American Depositary Share does not currently pay a dividend.

  • Dividend Growth

    Verona Pharma PLC American Depositary Share does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    4.77% of the outstanding shares of Verona Pharma PLC American Depositary Share have been sold short.
  • Short Interest Ratio / Days to Cover

    Verona Pharma PLC American Depositary Share has a short interest ratio ("days to cover") of 1.2, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Verona Pharma PLC American Depositary Share has recently increased by 6,533.99%, indicating that investor sentiment is decreasing significantly.
  • News Sentiment

    Verona Pharma PLC American Depositary Share has a news sentiment score of 0.51. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.39 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 34 news articles for Verona Pharma PLC American Depositary Share this week, compared to 9 articles on an average week.
  • Search Interest

    9 people have searched for VRNA on MarketBeat in the last 30 days. This is an increase of 80% compared to the previous 30 days.
  • MarketBeat Follows

    Only 4 people have added Verona Pharma PLC American Depositary Share to their MarketBeat watchlist in the last 30 days. This is a decrease of -43% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Verona Pharma PLC American Depositary Share insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $24,613,268.00 in company stock.

  • Percentage Held by Insiders

    Only 4.80% of the stock of Verona Pharma PLC American Depositary Share is held by insiders.

  • Percentage Held by Institutions

    85.88% of the stock of Verona Pharma PLC American Depositary Share is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Verona Pharma PLC American Depositary Share's insider trading history.
Receive VRNA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Verona Pharma PLC American Depositary Share and its competitors with MarketBeat's FREE daily newsletter.

VRNA Stock News Headlines

Is Elon's empire crumbling?
The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered a revolutionary AI breakthrough buried inside Tesla's labs. One that is helping AI escape from our computer screens and manifest itself here in the real world all while creating a 25,000% growth market explosion starting as early as October 23rd.
See More Headlines

VRNA Stock Analysis - Frequently Asked Questions

Verona Pharma PLC American Depositary Share's stock was trading at $46.44 on January 1st, 2025. Since then, VRNA stock has increased by 127.0% and is now trading at $105.40.

Verona Pharma PLC American Depositary Share (NASDAQ:VRNA) issued its quarterly earnings data on Wednesday, August, 6th. The company reported $0.13 EPS for the quarter, beating the consensus estimate of ($0.01) by $0.14. The firm had revenue of $103.14 million for the quarter, compared to the consensus estimate of $90.41 million. Verona Pharma PLC American Depositary Share had a negative net margin of 36.62% and a negative trailing twelve-month return on equity of 23.69%.

Verona Pharma PLC American Depositary Share (VRNA) raised $61 million in an initial public offering on Thursday, April 27th 2017. The company issued 4,500,000 shares at a price of $13.49 per share. Jefferies and Stifel served as the underwriters for the IPO and Wedbush PacGrow and SunTrust Robinson Humphrey were co-managers.

Top institutional shareholders of Verona Pharma PLC American Depositary Share include Jennison Associates LLC (1.03%), Allspring Global Investments Holdings LLC (0.62%), TD Asset Management Inc (0.26%) and Bank of New York Mellon Corp (0.12%). Insiders that own company stock include David Zaccardelli, Mark W Hahn, Orbimed Advisors Llc, Kathleen A Rickard, Claire Poll, David R Ebsworth, Andrew Fisher, Martin Edwards, Vikas Sinha, Mahendra Shah, Lisa Deschamps, Kenneth Cunningham, James Aloysius Brady and Michael Austwick.
View institutional ownership trends
.

Shares of VRNA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Verona Pharma PLC American Depositary Share investors own include Cisco Systems (CSCO), Philip Morris International (PM), NVIDIA (NVDA), Meta Platforms (META), Advanced Micro Devices (AMD), Home Depot (HD) and CrowdStrike (CRWD).

Company Calendar

Last Earnings
8/06/2025
Today
8/08/2025
Next Earnings (Estimated)
8/14/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED - BIOMED/GENE
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:VRNA
CIK
1657312
Fax
N/A
Employees
30
Year Founded
N/A

Price Target and Rating

High Price Target
$170.00
Low Price Target
$57.00
Potential Upside/Downside
+3.4%
Consensus Rating
Hold
Rating Score (0-4)
2.15
Research Coverage
13 Analysts

Profitability

EPS (Trailing Twelve Months)
($2.00)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$173.42 million
Net Margins
-36.62%
Pretax Margin
-130.46%
Return on Equity
-23.69%
Return on Assets
-9.63%

Debt

Debt-to-Equity Ratio
1.07
Current Ratio
8.86
Quick Ratio
8.73

Sales & Book Value

Annual Sales
$42.28 million
Price / Sales
212.22
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$2.56 per share
Price / Book
41.17

Miscellaneous

Outstanding Shares
85,130,000
Free Float
81,046,000
Market Cap
$8.97 billion
Optionable
Optionable
Beta
0.12

Social Links

Beginner's Guide To Retirement Stocks Cover

Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report

This page (NASDAQ:VRNA) was last updated on 8/8/2025 by MarketBeat.com Staff
From Our Partners